Trengestone

Trengestone
Systematic (IUPAC) name
(8S,9S,10R,13S,14S,17S)-17-acetyl-6-chloro-10,13-dimethyl-8,9,11,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
Identifiers
CAS Number 5192-84-7
ATC code None
PubChem CID 56840930
ChemSpider 16736068
Synonyms Ro 4-8347
Chemical data
Formula C21H25ClO2
Molar mass 344.875 g/mol

Trengestone (INN) (brand names Reteroid, Retroid, Retrone), also known as 1,6-bis-dehydro-6-chloro-retroprogesterone[1] or as 6-chloropregna-1,4,6-triene-3,20-dione, is a steroidal progestin that was introduced by Roche in 1974 and was formerly used to treat menstrual problems.[2][3][4]

See also

References

  1. Andreoli C, Fiorentino F, Lenzi G (September 1970). "[Clinical studies and endometrial histomorphological findings by means of a new retroprogesterone derivative: 1,6 bis dehydro-6-chloro-retroprogesterone (Trengestone)]". Minerva Ginecol (in Italian) 22 (18): 874–9. PMID 4925556.
  2. C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 2015–. ISBN 978-0-412-46630-4.
  3. Pascale Brudon (1983). Médicaments pour tous en l'an 2000?: les multinationales pharmaceutiques suisses face au tiers monde : l'exemple du Mexique. Editions d'en bas. pp. 93–. ISBN 978-2-8290-0039-3.
  4. Dr. Ian Morton; I.K. Morton; Judith M. Hall (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 279–. ISBN 978-0-7514-0499-9.



This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.